Abiopharma

New Form 8-K - PROTHENA CORP PUBLIC LTD CO Filed: 2025-06-16 AccNo: 0001193125-25-141098 Size: 165 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - NextCure, Inc. Filed: 2025-06-16 AccNo: 0001558370-25-008633 Size: 5 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form RW - IceCure Medical Ltd. Filed: 2025-06-16 AccNo: 0001213900-25-054484 Size: 7 KB

New Form 8-K - Cartesian Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001453687-25-000093 Size: 154 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - ELITE PHARMACEUTICALS INC /NV/ Filed: 2025-06-16 AccNo: 0001641172-25-015172 Size: 217 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - 23andMe Holding Co. Filed: 2025-06-16 AccNo: 0001193125-25-141090 Size: 185 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - AVIENT CORP Filed: 2025-06-16 AccNo: 0001193125-25-141088 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

New Form 8-K - Intellia Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001193125-25-141087 Size: 193 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Enliven Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001193125-25-141085 Size: 629 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - Haleon plc Filed: 2025-06-16 AccNo: 0001654954-25-006949 Size: 34 KB